Lemelson Capital Management Marks Flagship Fund's Second Anniversary Sep 5, 2014 09:03AM
Lemelson Capital Comments on Large Institutional Selling in Shares of Ligand Pharmaceuticals Amidst Company's Insolvency and Mounting Going Concern Risk Aug 25, 2014 11:43AM
Lemelson Capital Says Ligand Pharmaceuticals' $225M Debt Issuance Solidifies Company's Insolvency, Substantially Raises Specter of Bankruptcy Aug 14, 2014 09:15AM
Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Updates LGND Research Report with New Material Information Aug 4, 2014 02:46PM
Lemelson Capital Management Announces TTM and Second Quarter 2014 Performance Results for The Amvona Fund Jul 17, 2014 11:53AM


Jul 7, 2014 09:00AM Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Appends its LGND Research Report
Nov 14, 2011 04:56PM Loeb's Third Point LLC Hedge Fund Releases Q3 2011 13F
May 17, 2011 12:15PM Loeb's Third Point Hedge Fund Gets Out of Citigroup (C), Shows New Stakes in CBS (CBS) and eBay (EBAY) Among Others
Feb 18, 2010 01:38PM Loeb's Third Point Q4 13F Breakdown: Ups Bets In Financials, Exits Large Pharma
Nov 14, 2008 03:28PM Loeb's Third Point 13F; Shows New Stakes in BUD, C, CVS, MER, WEN, UST, Sells Out of MA